BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 37116861)

  • 1. Molecular characterization of Candida auris outbreak isolates in Qatar from patients with COVID-19 reveals the emergence of isolates resistant to three classes of antifungal drugs.
    Ben Abid F; Salah H; Sundararaju S; Dalil L; Abdelwahab AH; Salameh S; Ibrahim EB; Almaslmani MA; Tang P; Perez-Lopez A; Tsui CKM
    Clin Microbiol Infect; 2023 Aug; 29(8):1083.e1-1083.e7. PubMed ID: 37116861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
    J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses.
    Chow NA; Muñoz JF; Gade L; Berkow EL; Li X; Welsh RM; Forsberg K; Lockhart SR; Adam R; Alanio A; Alastruey-Izquierdo A; Althawadi S; Araúz AB; Ben-Ami R; Bharat A; Calvo B; Desnos-Ollivier M; Escandón P; Gardam D; Gunturu R; Heath CH; Kurzai O; Martin R; Litvintseva AP; Cuomo CA
    mBio; 2020 Apr; 11(2):. PubMed ID: 32345637
    [No Abstract]   [Full Text] [Related]  

  • 4. Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents.
    Jacobs SE; Jacobs JL; Dennis EK; Taimur S; Rana M; Patel D; Gitman M; Patel G; Schaefer S; Iyer K; Moon J; Adams V; Lerner P; Walsh TJ; Zhu Y; Anower MR; Vaidya MM; Chaturvedi S; Chaturvedi V
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0005322. PubMed ID: 35770999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.
    Lockhart SR; Etienne KA; Vallabhaneni S; Farooqi J; Chowdhary A; Govender NP; Colombo AL; Calvo B; Cuomo CA; Desjardins CA; Berkow EL; Castanheira M; Magobo RE; Jabeen K; Asghar RJ; Meis JF; Jackson B; Chiller T; Litvintseva AP
    Clin Infect Dis; 2017 Jan; 64(2):134-140. PubMed ID: 27988485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Analysis of Experimentally Evolved Candida auris Reveals Multiple Novel Mechanisms of Multidrug Resistance.
    Carolus H; Pierson S; Muñoz JF; Subotić A; Cruz RB; Cuomo CA; Van Dijck P
    mBio; 2021 Apr; 12(2):. PubMed ID: 33820824
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole genome sequencing analysis demonstrates therapy-induced echinocandin resistance in Candida auris isolates.
    Spruijtenburg B; Ahmad S; Asadzadeh M; Alfouzan W; Al-Obaid I; Mokaddas E; Meijer EFJ; Meis JF; de Groot T
    Mycoses; 2023 Dec; 66(12):1079-1086. PubMed ID: 37712885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterisation of Candida auris isolates from immunocompromised patients in a tertiary-care hospital in Kuwait reveals a novel mutation in FKS1 conferring reduced susceptibility to echinocandins.
    Asadzadeh M; Mokaddas E; Ahmad S; Abdullah AA; de Groot T; Meis JF; Shetty SA
    Mycoses; 2022 Mar; 65(3):331-343. PubMed ID: 34953089
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Maphanga TG; Naicker SD; Kwenda S; Muñoz JF; van Schalkwyk E; Wadula J; Nana T; Ismail A; Coetzee J; Govind C; Mtshali PS; Mpembe RS; Govender NP;
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0051721. PubMed ID: 34228535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide analysis of in vivo-evolved Candida auris reveals multidrug-resistance mechanisms.
    Chen XF; Zhang H; Liu LL; Guo LN; Liu WJ; Liu YL; Li DD; Zhao Y; Zhu RY; Li Y; Dai RC; Yu SY; Li J; Wang T; Dou HT; Xu YC
    Mycopathologia; 2024 Apr; 189(3):35. PubMed ID: 38637433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomics and Phenotyping Define Genetic Signatures Associated with Echinocandin Resistance in Candida auris.
    Jenull S; Shivarathri R; Tsymala I; Penninger P; Trinh PC; Nogueira F; Chauhan M; Singh A; Petryshyn A; Stoiber A; Chowdhary A; Chauhan N; Kuchler K
    mBio; 2022 Aug; 13(4):e0079922. PubMed ID: 35968956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upc2-mediated mechanisms of azole resistance in
    Li J; Aubry L; Brandalise D; Coste AT; Sanglard D; Lamoth F
    Microbiol Spectr; 2024 Feb; 12(2):e0352623. PubMed ID: 38206035
    [No Abstract]   [Full Text] [Related]  

  • 15.
    Maphanga TG; Mpembe RS; Naicker SD; Govender NP;
    Microbiol Spectr; 2022 Feb; 10(1):e0171721. PubMed ID: 35196811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs.
    Ahmad S; Khan Z; Al-Sweih N; Alfouzan W; Joseph L
    Mycoses; 2020 Jan; 63(1):104-112. PubMed ID: 31618799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
    Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
    [No Abstract]   [Full Text] [Related]  

  • 18. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delineation of the Direct Contribution of Candida auris
    Rybak JM; Sharma C; Doorley LA; Barker KS; Palmer GE; Rogers PD
    Microbiol Spectr; 2021 Dec; 9(3):e0158521. PubMed ID: 34878305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Epidemiology of
    Salah H; Sundararaju S; Dalil L; Salameh S; Al-Wali W; Tang P; Ben Abid F; Tsui CKM
    J Fungi (Basel); 2021 Mar; 7(3):. PubMed ID: 33807036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.